These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7018680)

  • 1. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
    Hahn RG; Begg CB; Davis T
    Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
    Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
    Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
    Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
    Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced adenocarcinoma of the kidney: therapy with lomustine, vinblastine, hydroxyurea, and medroxyprogesterone acetate and regression analysis of factors relating to survival.
    Brubaker LH; Troner MB; Birch R
    Cancer Treat Rep; 1983; 67(7-8):741-2. PubMed ID: 6223695
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Hahn RG; Bauer M; Wolter J; Creech R; Bennett JM; Wampler G
    Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
    Williams PD; Kantor P; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary metastasis of renal cell carcinoma].
    Satomi Y
    Gan No Rinsho; 1983 May; 29(6):555-60. PubMed ID: 6876423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib for the treatment of advanced renal cell carcinoma.
    Kane RC; Farrell AT; Saber H; Tang S; Williams G; Jee JM; Liang C; Booth B; Chidambaram N; Morse D; Sridhara R; Garvey P; Justice R; Pazdur R
    Clin Cancer Res; 2006 Dec; 12(24):7271-8. PubMed ID: 17189398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
    Nichols WC; Kvols LK; Ingle JN; Edmonson JH; Ahmann DL; Rubin J; O'Connell MJ
    Cancer Treat Rep; 1978 May; 62(5):837-9. PubMed ID: 657166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma.
    Kuebler JP; Hogan TF; Trump DL; Bryan GT
    Cancer Treat Rep; 1984 Jun; 68(6):925-6. PubMed ID: 6733709
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
    Thongprasert S; Chewaskulyong B
    J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
    Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
    Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced renal cell carcinoma with vinblastine and CCNU.
    Merrin C; Mittelman A; Fanous N; Walsman Z; Murphy GP
    J Urol; 1975 Jan; 113(1):21-3. PubMed ID: 1113389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.